153 related articles for article (PubMed ID: 26076441)
41. Multifunctional immune-modulatory protein HLA-E identified in classical Hodgkin lymphoma: possible implications.
Kren L; Fabian P; Slaby O; Janikova A; Soucek O; Sterba J; Krenova Z; Michalek J; Kral Z
Pathol Res Pract; 2012 Jan; 208(1):45-9. PubMed ID: 22177730
[TBL] [Abstract][Full Text] [Related]
42. Cytotoxic protein expression in non-Hodgkin's lymphomas and Hodgkin's disease.
Kanavaros P; Vlychou M; Stefanaki K; Rontogianni D; Gaulard P; Pantelidaki E; Zois M; Darivianaki K; Georgoulias V; Boulland ML; Gorgoulis V; Kittas C
Anticancer Res; 1999; 19(2A):1209-16. PubMed ID: 10368677
[TBL] [Abstract][Full Text] [Related]
43. T-cell-derived Hodgkin lymphoma has motility characteristics intermediate between Hodgkin and anaplastic large cell lymphoma.
Bein J; Flinner N; Häupl B; Mathur A; Schneider O; Abu-Ayyad M; Hansmann ML; Piel M; Oellerich T; Hartmann S
J Cell Mol Med; 2022 Jun; 26(12):3495-3505. PubMed ID: 35586951
[TBL] [Abstract][Full Text] [Related]
44. High tumour plasma cell infiltration reflects an important microenvironmental component in classic Hodgkin lymphoma linked to presence of B-symptoms.
Gholiha AR; Hollander P; Hedstrom G; Sundstrom C; Molin D; Smedby KE; Hjalgrim H; Glimelius I; Amini RM; Enblad G
Br J Haematol; 2019 Jan; 184(2):192-201. PubMed ID: 30506671
[TBL] [Abstract][Full Text] [Related]
45. CD81 protein is expressed at high levels in normal germinal center B cells and in subtypes of human lymphomas.
Luo RF; Zhao S; Tibshirani R; Myklebust JH; Sanyal M; Fernandez R; Gratzinger D; Marinelli RJ; Lu ZS; Wong A; Levy R; Levy S; Natkunam Y
Hum Pathol; 2010 Feb; 41(2):271-80. PubMed ID: 20004001
[TBL] [Abstract][Full Text] [Related]
46. Repression of TCF3/E2A contributes to Hodgkin lymphomagenesis.
Guan H; Xie L; Wirth T; Ushmorov A
Oncotarget; 2016 Jun; 7(24):36854-36864. PubMed ID: 27166193
[TBL] [Abstract][Full Text] [Related]
47. Immune-Proteome Profiling in Classical Hodgkin Lymphoma Tumor Diagnostic Tissue.
Gholiha AR; Hollander P; Löf L; Larsson A; Hashemi J; Ulfstedt JM; Molin D; Amini RM; Freyhult E; Kamali-Moghaddam M; Enblad G
Cancers (Basel); 2021 Dec; 14(1):. PubMed ID: 35008176
[TBL] [Abstract][Full Text] [Related]
48. Fine-tuning of FOXO3A in cHL as a survival mechanism and a hallmark of abortive plasma cell differentiation.
Osswald CD; Xie L; Guan H; Herrmann F; Pick SM; Vogel MJ; Gehringer F; Chan FC; Steidl C; Wirth T; Ushmorov A
Blood; 2018 Apr; 131(14):1556-1567. PubMed ID: 29439954
[TBL] [Abstract][Full Text] [Related]
49. Global phosphoproteomic profiling reveals distinct signatures in B-cell non-Hodgkin lymphomas.
Rolland D; Basrur V; Conlon K; Wolfe T; Fermin D; Nesvizhskii AI; Lim MS; Elenitoba-Johnson KS
Am J Pathol; 2014 May; 184(5):1331-42. PubMed ID: 24667141
[TBL] [Abstract][Full Text] [Related]
50. Lack of HER-2/neu expression in Hodgkin and non-Hodgkin lymphoma.
Bairey O; Pazgal I; Okon E; Shaklai M; Morgenshtern S
Arch Pathol Lab Med; 2002 May; 126(5):574-6. PubMed ID: 11958663
[TBL] [Abstract][Full Text] [Related]
51. Proteomic analysis identifies galectin-1 as a predictive biomarker for relapsed/refractory disease in classical Hodgkin lymphoma.
Kamper P; Ludvigsen M; Bendix K; Hamilton-Dutoit S; Rabinovich GA; Møller MB; Nyengaard JR; Honoré B; d'Amore F
Blood; 2011 Jun; 117(24):6638-49. PubMed ID: 21505194
[TBL] [Abstract][Full Text] [Related]
52. Clonal relationship of relapsing lymphoid neoplasms.
Obermann EC; Dirnhofer S; Tzankov A
Histol Histopathol; 2012 Aug; 27(8):1013-20. PubMed ID: 22763873
[TBL] [Abstract][Full Text] [Related]
53. Accuracy of Pathologic Diagnosis in Patients With Lymphoma and Survival: A Prospective Analysis From Botswana.
Chipidza FE; Kayembe MKA; Nkele I; Efstathiou JA; Chabner BA; Abramson J; Dryden-Peterson SL; Sohani AR
JCO Glob Oncol; 2021 Sep; 7():1620-1632. PubMed ID: 34860565
[TBL] [Abstract][Full Text] [Related]
54. Evaluation of a panel of expert pathologists: review of the diagnosis and histological classification of Hodgkin and non-Hodgkin lymphomas in a population-based cancer registry.
Strobbe L; van der Schans SA; Heijker S; Meijer JW; Mattijssen EJ; Mandigers CM; de Kievit IM; Raemaekers JM; Hebeda KM; van Krieken JH
Leuk Lymphoma; 2014 May; 55(5):1018-22. PubMed ID: 23885798
[TBL] [Abstract][Full Text] [Related]
55. Pharmacological restoration and therapeutic targeting of the B-cell phenotype in classical Hodgkin lymphoma.
Du J; Neuenschwander M; Yu Y; Däbritz JH; Neuendorff NR; Schleich K; Bittner A; Milanovic M; Beuster G; Radetzki S; Specker E; Reimann M; Rosenbauer F; Mathas S; Lohneis P; Hummel M; Dörken B; von Kries JP; Lee S; Schmitt CA
Blood; 2017 Jan; 129(1):71-81. PubMed ID: 27733358
[TBL] [Abstract][Full Text] [Related]
56. Leukemia surfaceome analysis reveals new disease-associated features.
Mirkowska P; Hofmann A; Sedek L; Slamova L; Mejstrikova E; Szczepanski T; Schmitz M; Cario G; Stanulla M; Schrappe M; van der Velden VH; Bornhauser BC; Wollscheid B; Bourquin JP
Blood; 2013 Jun; 121(25):e149-59. PubMed ID: 23649467
[TBL] [Abstract][Full Text] [Related]
57. PiwiRNA-651 as marker of treatment response and survival in classical Hodgkin lymphoma.
Cordeiro A; Navarro A; Gaya A; Díaz-Beyá M; Gonzalez-Farré B; Castellano JJ; Fuster D; Martínez C; Martínez A; Monzó M
Oncotarget; 2016 Jul; 7(29):46002-46013. PubMed ID: 27329591
[TBL] [Abstract][Full Text] [Related]
58. Pathogenic Variants Associated with Epigenetic Control and the NOTCH Pathway Are Frequent in Classic Hodgkin Lymphoma.
Santisteban-Espejo A; Bernal-Florindo I; Montero-Pavon P; Perez-Requena J; Atienza-Cuevas L; Fernandez-Valle MDC; Villalba-Fernandez A; Garcia-Rojo M
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473705
[TBL] [Abstract][Full Text] [Related]
59. Proteomic cell surface phenotyping of differentiating acute myeloid leukemia cells.
Hofmann A; Gerrits B; Schmidt A; Bock T; Bausch-Fluck D; Aebersold R; Wollscheid B
Blood; 2010 Sep; 116(13):e26-34. PubMed ID: 20570859
[TBL] [Abstract][Full Text] [Related]
60. A practical approach to the diagnosis of Hodgkin lymphoma.
Listinsky CM
Am J Clin Pathol; 2002 Jun; 117 Suppl():S76-94. PubMed ID: 14569804
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
